Key result
A novel delivery technique for the Sapien S3 valve greatly simplified valve delivery into the right ventricular outflow tract and may potentially reduce the risk of tricuspid valve injury.
Case Report
A novel delivery technique for the Sapien S3 valve may simplify transcatheter pulmonary valve replacement and reduce the risk of tricuspid valve injury.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for simplified Sapien S3 delivery in transcatheter pulmonary valve replacement.
Transcatheter pulmonary valve replacement (TPVR) is now common practice in patients with significant pulmonary regurgitation (PR), stenosis (PS), or mixed pulmonary valve disease. While the Melody valve (Medtronic, Inc.) and its delivery system were specifically designed for use in the right ventricular outflow tract (RVOT), Sapien valves (XT and S3, Edwards Lifesciences, Inc.) and their delivery systems (Novaflex and Commander) were not. As a result, placement of Sapien valves in the RVOT can be challenging secondary to the stiffness of the current delivery system. Manipulating a stiff delivery system within the RV also introduces risk to the tricuspid valve and its chordal attachments. We report a novel delivery technique for the Sapien S3 valve which has greatly simplified valve delivery into the RVOT and may potentially reduce the risk of tricuspid valve injury.
No takes yet. Share an insight, caveat, or question.
Shahanavaz et al. (2018) conducted a case report in Significant pulmonary regurgitation, stenosis, or mixed pulmonary valve disease. Novel delivery technique for the Sapien S3 valve was evaluated. A novel delivery technique for the Sapien S3 valve greatly simplified valve delivery into the right ventricular outflow tract and may potentially reduce the risk of tricuspid valve injury.
Synapse has enriched 10 related papers. Consider them for comparative context: